Advertisement
-
1
Eldor R, Raz I, Ben YA, et al: New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies. .Diabet Med 21::1161. ,2004. .
-
2
Phillips TJ: Successful methods of treating leg ulcers: the tried and true, plus the novel and new. .Postgrad Med 105::159. ,1999. .
-
3
Aminian B, Shams M, Soveyd M, et al: Topical autologous platelet-derived growth factors in the treatment of chronic diabetic ulcers. .Arch Iran Med (April):3. ,2000. .
-
4
Margolis DJ, Kantor J, Santanna J, et al: Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. .Diabetes Care 24::483. ,2001. .
-
5
Trent JT, Falabella A, Eaglstein WH, et al: Venous ulcers: pathophysiology and treatment options. .Ostomy Wound Manage 51::38. ,2005. .
-
6
Abbade LP, Lastoria S, de Almeida Rollo H, et al: A sociodemographic, clinical study of patients with venous ulcer. .Int J Dermatol 44::989. ,2005. .
-
7
Agren MS, Eaglstein WH, Ferguson MW, et al: Causes and effects of the chronic inflammation in venous leg ulcers. .Acta Derm Venereol Suppl (Stockh) 210::3. ,2000. .
-
8
Raffetto JD, Vasquez R, Goodwin DG, et al: Mitogen-activated protein kinase pathway regulates cell proliferation in venous ulcer fibroblasts. .Vasc Endovasc Surg 40::59. ,2006. .
-
9
Sieggreen MY, Kline RA: Arterial insufficiency and ulceration: diagnosis and treatment options. .Nurse Pract 29::46. ,2004. .
-
10
Weitz JI, Byrne J, Clagett GP, et al: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. .Circulation 94::3026. ,1996. .
-
11
Bouza C, Munoz A, Amate JM: Efficacy of modern dressings in the treatment of leg ulcers: a systematic review. .Wound Repair Regen 13::218. ,2005. .
-
12
Sharma S, McAleer JP: Debriding wounds with the Versajet hydrosurgery system. .Podiatry Manage 24::127. ,2005. .
-
13
Fu X, Li X, Cheng B, et al: Engineered growth factors and cutaneous wound healing: success and possible questions in the past 10 years. .Wound Repair Regen 13::122. ,2005. .
-
14
Ross R, Raines EW, Bowen-Pope DF: The biology of platelet-derived growth factor. .Cell 46::155. ,1986. .
-
15
Mulder GD: Standardizing wound treatment procedures for advanced technologies. .JAPMA 92::7. ,2002. .
-
16
Eppley BL, Woodell JE, Higgins J: Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. .Plast Reconstr Surg 114::1502. ,2004. .
-
17
Crovetti G, Martinelli G, Issi M, et al: Platelet gel for healing cutaneous chronic wounds. .Transfus Apher Sci 30::145. ,2004. .
Efficacy of Concentrated Autologous Platelet-Derived Growth Factors in Chronic Lower-Extremity Wounds
Search for other papers by Jody Peter McAleer in
Current site
Google Scholar
PubMed
Search for other papers by Eric Kaplan in
Current site
Google Scholar
PubMed
Search for other papers by Gianni Persich in
Current site
Google Scholar
PubMed
The efficacy of concentrated autologous platelet-derived growth factors in the healing and closure of chronic lower-extremity wounds was evaluated in 24 patients with 33 lower-extremity wounds treated previously for at least 6 months using traditional methods. Surgical wound debridement was performed to convert chronic ulcers into acute wounds. Concentrated autologous platelet-derived growth factors and thrombin were applied to the wound bases and protected with a nonadhering compression dressing that remained intact for 7 days. Wounds were evaluated and the concentrate was reapplied every 2 weeks. Wound closure and complete epithelialization was achieved in 20 wounds. Seventy-five percent or greater wound closure was obtained in three wounds, 50% to 74% closure in three wounds, and 25% to 49% closure in two wounds. Five wounds displayed no improvement. Mean time to complete closure was 11.15 weeks. The application of concentrated autologous platelet-derived growth factors and thrombin resulted in substantial wound healing and wound-diameter reduction. This technique constitutes a safe and effective treatment option and avoids lengthy treatment periods that increase the potential for infection. (J Am Podiatr Med Assoc 96(6): 482–488, 2006)
